SageTech

SageTech has developed, prototyped, and patented systems to capture, extract and purify inhalational anaesthetic emissions, creating a circular economy for a formerly wasteful pharmaceutical product.

The systems enable cost and emissions savings, flexible theatre design and increased access to clinically superior anaesthetics. Captured used anaesthetic gas is recycled, promoting the circular economy of this market and opening up the global veterinary and human healthcare sectors.

This technology can reduce hospital costs, reduce harmful greenhouse gas emissions, and enable flexible hospital space usage.

The company has commenced final pre-commercialisation testing with NHS Trusts, is backed by experienced investors and Innovate UK Grant funding.

Disclaimer

Investing in start-ups and early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution. It should be done only as part of a diversified portfolio. Any investments are targeted exclusively at investors who understand the risks of investing in early-stage businesses and can make their own investment decisions. Any pitches for investment are not offers to the public.

Investments made in investee companies via funds managed by Sapphire Capital Partners LLP are not covered by the Financial Services Compensation Scheme (FSCS). For more details, please contact us or refer to their website: https://www.fscs.org.uk